Pseudohypoparathyroidism Diagnosis and Management
Diagnostic Considerations
- The Endocrine Society recommends assessing vitamin D status before finalizing the diagnosis of pseudohypoparathyroidism, aiming for 25-OH vitamin D levels >20 ng/mL (50 nmol/L), as vitamin D deficiency can cause secondary hyperparathyroidism with similar biochemical features 1
- Evaluating dietary calcium intake through detailed dietary history is crucial, as calcium deprivation can mimic pseudohypoparathyroidism biochemically, and low urinary calcium suggests inadequate calcium intake rather than true pseudohypoparathyroidism 1
Laboratory Testing
- The American Association for Clinical Chemistry advises being aware that different PTH assay generations have variable sensitivity to PTH fragments, which can affect interpretation, and always using assay-specific reference ranges when interpreting PTH values 2
- The National Institute of Diabetes and Digestive and Kidney Diseases suggests that serum 25-OH vitamin D levels should be measured to exclude vitamin D deficiency, and 1,25-dihydroxyvitamin D levels may be inappropriately low for age despite normal adult range 3
Differential Diagnosis
- The American College of Radiology recommends distinguishing pseudohypoparathyroidism from primary hyperparathyroidism, which presents with hypercalcemia and elevated PTH rather than hypocalcemia, and the calcium level immediately distinguishes these conditions 4
Pseudohipoparatiroidismo: Diagnóstico y Tratamiento
Diagnóstico
- Medir simultáneamente calcio sérico (corregido por albúmina) y PTH intacta para el diagnóstico preciso 5
Tratamiento
- Proporcionar carbonato de calcio cuando la ingesta oral sea posible 5
- Monitorear calcio y fósforo séricos cada 2 semanas durante 1 mes después del inicio o aumento de dosis, luego mensualmente 6
- Monitorear PTH mensualmente durante al menos 3 meses, luego cada 3 meses una vez alcanzados los niveles objetivo 6
- Evaluar el estado de vitamina D, ya que no hacerlo puede complicar la interpretación de los niveles de PTH 5
Consideraciones Especiales
- Los calcimiméticos (cinacalcet) no están indicados en PHP, ya que el problema es resistencia a PTH, no exceso de producción 7
- Evitar usar valores de corte absolutos de PTH sin especificar el ensayo utilizado, ya que diferentes generaciones de ensayos tienen sensibilidad variable a los fragmentos de PTH 7, 5